ATLAS / Macro Radar / Reporting / CGON

CG Oncology, Inc. (CGON) reporting calendar

CG Oncology, Inc. files periodic reports with the SEC as CGON on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
8 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CGON market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20268 May 202638 days0001193125-26-214669
10-K31 Dec 202527 Feb 202658 days0001193125-26-079498
10-Q30 Sep 202514 Nov 202545 days0001193125-25-283000
10-Q30 Jun 20258 Aug 202539 days0000950170-25-105855
10-Q31 Mar 202513 May 202543 days0000950170-25-069831
10-K31 Dec 202428 Mar 202587 days0000950170-25-046351
10-Q30 Sep 202412 Nov 202443 days0000950170-24-124642
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093238
10-Q31 Mar 20249 May 202439 days0000950170-24-056196
10-K31 Dec 202326 Mar 202486 days0000950170-24-036143

Source: SEC EDGAR company submissions for CIK 0001991792. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.